Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy.

Udagawa R, Shimokawa M, Iihara H, Ozeki R, Tsuneizumi M, Futamura M, Fujita T, Ogata H, Bando H, Uomori T, Hashimoto H, Hayami R, Tokumaru Y, Kutomi G, Yonemori K, Matsunuma R, Kitahora M, Yanagisawa N, Shimoi T, Saito M

Open source

DOI: 10.1093/oncolo/oyag351
Published: 2026 Sep 9
Container: The oncologist
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag351,
  title = {Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy.},
  author = {Udagawa R and Shimokawa M and Iihara H and Ozeki R and Tsuneizumi M and Futamura M and Fujita T and Ogata H and Bando H and Uomori T and Hashimoto H and Hayami R and Tokumaru Y and Kutomi G and Yonemori K and Matsunuma R and Kitahora M and Yanagisawa N and Shimoi T and Saito M},
  year = {2026},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyag351},
  url = {https://doi.org/10.1093/oncolo/oyag351}
}

RIS

TY  - JOUR
TI  - Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy.
AU  - Udagawa R
AU  - Shimokawa M
AU  - Iihara H
AU  - Ozeki R
AU  - Tsuneizumi M
AU  - Futamura M
AU  - Fujita T
AU  - Ogata H
AU  - Bando H
AU  - Uomori T
AU  - Hashimoto H
AU  - Hayami R
AU  - Tokumaru Y
AU  - Kutomi G
AU  - Yonemori K
AU  - Matsunuma R
AU  - Kitahora M
AU  - Yanagisawa N
AU  - Shimoi T
AU  - Saito M
PY  - 2026
JO  - The oncologist
DO  - 10.1093/oncolo/oyag351
UR  - https://doi.org/10.1093/oncolo/oyag351
ER  -

APA

R, U., M, S., H, I., R, O., M, T., M, F., T, F., H, O., H, B., T, U., H, H., R, H., Y, T., G, K., K, Y., R, M., M, K., N, Y., T, S., & M, S. (2026). Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy.. The oncologist. https://doi.org/10.1093/oncolo/oyag351

Source records

pubmed · retrieved 2026-09-26T09:10:53.669Z